Market Flash: iSHARES MSCI Indonesia Investable Market Index Fund (EIDO:US) PRICE: 28.530 USD Down -0.360 (-1.246%) >>> BI: Rupiah Melemah Akibat Kondisi Eropa >>> Pertemuan FED pertimbangkan langkah baru dorong ekonomi >>> KIJA akan Terbitkan MEN Valas USD150 Juta >>> PT Indika Energy Perusahaan Teladan Dunia 2011 >>> Govt Promises Revision of Cost Recovery Regulation >>> BPMigas Demands PGN to Pay US$6 per MMBTU >>> Jababeka to Raise US$150 Million from Debt Markets >>> SCG Chemicals buys Chandra Asri >>> Solusi Tunas eyes Rp380 bio IPO >>> SMR Utama scouts Rp300 bio IPO >>> Alam Sutera picks two bond arrangers >>> ASII Tetap Rajai Penjualan Mobil Agustus 2011 >>> Perusahaan Thailand kuasai Saham TPIA senilai Rp 3,76 Triliun >>> Agis Main ke Tambang, Sahamnya Masuk Dalam Pengawasan >>> ACES Mendekati The Northern Agar Mau Kurangi Kepemilikan >>> IHSG masih harus berjuang terus bertahan diatas MA200 >>> Melirik Peluang Akumulasi di Saham Perbankan >>> Analisa Saham BUMI: Kuat Bertahan & Berpeluang Kembali Uptrend >>> Analisa Saham JSMR: Bertahan Di Support, What Next? >>> INDF Tertahan Di Area Support Kuat, Berpeluang Rebound >>> ASII Break Minor Support, Sell on Strength >>> ADRO Membentuk Descending Wedges, Berpeluang Rebound Terbatas >>> Wall Street ends flat as early gains evaporate >>> Fed begins policy meeting, tiptoes toward easing >>> Fed meeting to help decide on long-term Treasuries >>> Greece Makes 'Good Progress' in Reform Talks: EC >>> China worried Europe debt crisis will hit trade >>> China could roll out 4.65tr yuan stimulus package >>> IMF sees Mideast stagnation >>> NYMEX-Crude ends higher at Oct contract expiry >>> Asian Crude Palm Oil Up On Technical Buying, Soyoil >>> Foreign net Sell - 61.785.746

Jumat, 05 Agustus 2011

Medco Energi: Key takeaways from analyst meeting (MEDC, Rp2,525, Neutral, TP: Rp3,200) - Mandiri

􀂄 We attended Medco Energi (MEDC) analyst meeting and highlighted several points 􀂄 Management changes occur with new board positions:
(i) Lukman Mahfoedz, CEO, previously Project Director (now dispensed)
(ii) Syamsurizal Munaf, CFO, previously a Technical Director in Medco E&P Indonesia, has been in MEDC group level since 1997
(iii) Dasril Dahya, Human Capital previously Producing Asset Director in Medco E&P Indonesia, with Geologist background, has served around 30 years in MEDC
(iv) Frila Berlini Yaman, COO E&P, has a long experience in global oil companies
(v) Akira Mizuta, Chief Planning Officer, a representative from Mitsubishi.
􀂄 We noted MEDC now has two COO, with different focus (E&P and non-E&P business) and more boards at MEDC level (previously positioned in Medco E&P Indonesia group)
􀂄 As expected, revenue growth was mainly driven by strong oil price ASP at US$113.2/bbl (+40.7%yoy), mitigating oil lifting decline to 29.3mbopd (-4.5%yoy). On the other hand, gas production grew at high single digit to 159.6mmscfd (+9.7%yoy) mainly came from Lematang block.
􀂄 In terms of reserves, MEDC is still faced a declining trend with 2P reserves at 243mmboe (vs 3M11: 248mmboe). However, there is a potential reserve may come from Lika well in SCS block as MEDC conducted exploration efforts recently.
􀂄 We are reviewing our forecast on MEDC, currently traded at EV/2P US$5.2/boe

Tidak ada komentar:

Poskan Komentar